R. von Essen

RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION

M Verstraete, M Bory, D Collen et al. · The Lancet · 1985 · 752 citations

Thrombosis, Cardiovascular Disease, Fibrinolysis +10

Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)

K. L. Neuhaus, R. von Essen, Ulrich Tebbe et al. · Circulation · 1994 · 283 citations · Full text

Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: Retrospective analysis of four german multicenter studies

Albrecht Vogt, R. von Essen, Ulrich Tebbe et al. · Journal of the American College of Cardiology · 1993 · 264 citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +12

DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTION

M Verstraete, Ronald W. Brower, D Collen et al. · The Lancet · 1985 · 240 citations

Thrombosis, Cardiovascular Disease, Atherosclerosis +12

Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: An important determinant of survival

Florence H. Sheehan, Rolf Doerr, Wolfgang Schmidt et al. · Journal of the American College of Cardiology · 1988 · 203 citations

Thrombosis, Heart Failure, Cardiogenic Shock +10